Strategies to Implement Robust Validation of Clinical Biomarkers to Ensure Reimbursement of CDx & Accuracy of Clinical Studies
Time: 9:40 am
day: Day Three AM
Details:
- Maximizing the analytic accuracy & precision for biomarkers in diverse patient populations to support reimbursement claims
- Establishing best practices for demonstrating the biological and clinical relevance of a biomarker in disease diagnosis and prognosis, & treatment paradigms to facilitate payer acceptance
- Defining the difference between the presence of data and establishing clinical utility to meet reimbursement criteria parameters
